Literature DB >> 17297424

Gene therapy of liver cancer.

Rubén Hernández-Alcoceba1, Bruno Sangro, Jesús Prieto.   

Abstract

Gene therapy of liver cancer covers a variety of gene transfer strategies aimed to the treatment of patients with primary and secondary liver tumors, including gene directed enzyme/pro-drug therapy, inhibition of oncogenes and restoration of tumor-suppressor genes, immunotherapy, anti-angiogenesis and virotherapy. Some of these strategies have reached early clinical development with diverse little success.

Entities:  

Mesh:

Year:  2007        PMID: 17297424

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

1.  Recombinant adenovirus expressing a dendritic cell-targeted melanoma surface antigen for tumor-specific immunotherapy in melanoma mice model.

Authors:  Li-Li Guo; Gang-Cheng Wang; Peng-Jie Li; Cui-Mei Wang; Lin-Bo Liu
Journal:  Exp Ther Med       Date:  2018-04-23       Impact factor: 2.447

2.  Adenovirus-mediated combined anti-angiogenic and pro-apoptotic gene therapy enhances antitumor efficacy in hepatocellular carcinoma.

Authors:  Fei Yan; Yi Zheng; Laiqiang Huang
Journal:  Oncol Lett       Date:  2012-10-23       Impact factor: 2.967

3.  Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer.

Authors:  Hai-Yong Chen; Yao-Min Chen; Jian Wu; Fu-Chun Yang; Zhen Lv; Yi-Gang Qian; Shu-Sen Zheng
Journal:  Onco Targets Ther       Date:  2017-02-13       Impact factor: 4.147

Review 4.  Immunotherapy for liver tumors: present status and future prospects.

Authors:  Pablo Matar; Laura Alaniz; Viviana Rozados; Jorge B Aquino; Mariana Malvicini; Catalina Atorrasagasti; Manuel Gidekel; Marcelo Silva; O Graciela Scharovsky; Guillermo Mazzolini
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

5.  The liver as a target organ for gene therapy: state of the art, challenges, and future perspectives.

Authors:  Frank Jacobs; Stephanie C Gordts; Ilayaraja Muthuramu; Bart De Geest
Journal:  Pharmaceuticals (Basel)       Date:  2012-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.